ZnO Nanowire Arrays on 3D Hierachical Graphene Foam: Biomarker Detection of Parkinson’s Disease
- 13 January 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 8 (2) , 1639-1646
Abstract
We report that vertically aligned ZnO nanowire arrays (ZnO NWAs) were fabricated on 3D graphene foam (GF) and used to selectively detect uric acid (UA), dopamine (DA), and ascorbic acid (AA) by a differential pulse voltammetry method. The optimized ZnO NWA/GF electrode provided a high surface area and high selectivity with a detection limit of 1 nM for UA and DA. The high selectivity in the oxidation potential was explained by the gap difference between the lowest unoccupied and highest occupied molecular orbitals of a biomolecule for a set of given electrodes. This method was further used to detect UA levels in the serum of patients with Parkinson’s disease (PD). The UA level was 25% lower in PD patients than in healthy individuals. This finding strongly implies that UA can be used as a biomarker for PD.Keywords
This publication has 28 references indexed in Scilit:
- Synthesis, optical properties, and chemical–biological sensing applications of one-dimensional inorganic semiconductor nanowiresProgress in Materials Science, 2013
- A roadmap for grapheneNature, 2012
- Flexible graphene-based lithium ion batteries with ultrafast charge and discharge ratesProceedings of the National Academy of Sciences, 2012
- Premotor biomarkers for Parkinson's disease - a promising direction of researchTranslational Neurodegeneration, 2012
- Synthesis, computational, spectroscopic, thermal and antimicrobial activity studies on some metal–urate complexesSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2012
- Simultaneous electrochemical sensing of ascorbic acid, dopamine and uric acid at anodized nanocrystalline graphite-like pyrolytic carbon film electrodeAnalytica Chimica Acta, 2012
- Electrochemical sensor based on nitrogen doped graphene: Simultaneous determination of ascorbic acid, dopamine and uric acidBiosensors and Bioelectronics, 2012
- Urate: A Novel Biomarker of Parkinson‘s Disease Risk, Diagnosis and PrognosisBiomarkers in Medicine, 2010
- Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson DiseaseArchives of Neurology, 2008
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988